STAGE IIIB LUNG CANCER AJCC V8
Clinical trials for STAGE IIIB LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIB LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy boost after lung cancer surgery shows promise in major trial
Disease control Recruiting nowThis study looks at whether adding the immunotherapy drug pembrolizumab to standard chemotherapy after lung cancer surgery can help people live longer without the cancer coming back. About 1,210 adults with stage II to IIIB non-small cell lung cancer that was removed by surgery w…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 28, 2026 23:52 UTC
-
New combo therapy aims to extend life in aggressive lung cancer
Disease control Recruiting nowThis study tests whether adding bevacizumab to the standard drug osimertinib helps people with advanced EGFR-mutant non-small cell lung cancer live longer without their cancer growing. About 300 adults with stage IIIB or IV disease will receive either the combination or osimertin…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
Simple breathing workouts before lung surgery may cut pneumonia risk
Symptom relief Recruiting nowThis study tests whether doing special breathing exercises for several weeks before lung cancer surgery can lower the chance of serious lung problems like pneumonia or breathing failure after the operation. About 220 adults with stage I to IIIB lung cancer will either do the brea…
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Apr 28, 2026 23:51 UTC
-
Can personalized chemoradiation protect lung cancer Patients' hearts?
Knowledge-focused Recruiting nowThis study looks at how chemoradiation for locally advanced lung cancer affects the heart. Researchers will track heart injury and fitness in 100 patients, using each person's risk profile to tailor treatment and potentially lower heart complications. The goal is to learn how to …
Matched conditions: STAGE IIIB LUNG CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Apr 28, 2026 23:51 UTC